commend
articl
newman
et
al
increas
pool
academ
orient
africanamerican
medic
surgic
oncologist
highlight
issu
worthi
seriou
consider
must
effort
expend
rais
interest
african
american
medic
student
physician
academ
oncolog
disproportion
low
represent
african
american
medic
school
also
must
recogn
partli
wholli
system
failur
worthi
correct
attent
oncolog
commun
take
object
look
factor
gave
rise
continu
perpetu
unrepres
oncolog
workforc
exclud
african
american
state
affair
aros
histor
basi
unabash
white
privileg
justifi
illus
insepar
racial
superior
inferior
beneficiari
apartheidscal
privileg
understand
loath
know
magnitud
sometim
stellar
achiev
stand
diminish
contextu
foundat
cultur
insensit
exclus
even
notabl
contemporari
academ
oncologist
condemn
cancer
dispar
affect
popul
treat
insuffici
gener
recognit
dispar
among
mani
academ
oncologist
larg
selfappoint
near
exclus
privileg
manag
social
institut
resourc
mandat
research
solut
scarc
american
medic
oncologist
african
american
undoubtedli
case
oncolog
subspecialti
well
figur
best
approxim
thorough
demograph
studi
oncolog
workforc
publish
preemin
cancer
specialti
societi
american
societi
clinic
oncolog
describ
membership
includ
medic
oncologist
describ
african
american
academ
oncolog
surrog
indic
race
appear
supplant
overt
racism
preserv
deterr
repres
inclus
african
american
faculti
posit
colorblind
precis
network
faculti
member
influenc
oncologist
staf
metropolitan
commun
hospit
basi
market
exclus
african
american
cancer
specialist
establish
commun
african
american
live
larg
number
superfici
valid
state
affair
may
suggest
critic
rigor
sound
meritocraci
fail
conclus
lie
preval
dispar
cancer
mortal
among
popul
treat
mostli
commend
healer
altruist
intent
social
evolv
boundari
requisit
cultur
experi
labor
believ
better
job
would
done
us
work
togeth
cur
intent
address
dispar
constitut
societi
cancer
burden
w
e
appreci
dr
taylor
concern
respons
previou
articl
lack
ethnic
divers
within
medic
oncolog
commun
particular
notabl
deficit
african
american
oncologist
contribut
ethnicityrel
cancer
outcom
dispar
observ
unit
state
appropri
issu
receiv
increas
scrutini
time
legal
affirm
action
face
judici
challeng
medic
oncolog
commun
must
either
will
accept
limit
ethnic
heterogen
result
potenti
increas
difficulti
deliv
optim
care
ethnic
divers
patient
popul
must
proactiv
strengthen
divers
ethnic
composit
demograph
american
popul
shift
direct
larger
minorityethn
commun
trend
influenc
medic
commun
would
want
howev
exert
measur
control
extent
member
medic
commun
reflect
divers
patient
complianc
implement
clinic
trial
complet
depend
patient
trust
accept
concept
patient
like
readili
trust
health
care
commun
reflect
divers
cultur
valu
ethnic
imper
aggress
address
correct
defici
area
accomplish
energet
mentorship
recruit
effort
n
correspond
report
experi
use
mediastin
irradi
treatment
patient
esophag
carcinoma
year
heart
transplant
number
heart
transplant
perform
appear
increas
everi
year
surviv
patient
reportedli
improv
use
cyclosporin
immunosuppress
patient
longterm
survivor
risk
treat
oncolog
depart
increas
time
mani
patient
undergo
organ
transplant
develop
precancer
lesion
malign
tumor
cancer
requir
radiat
targetvolum
involv
part
transplant
heart
number
question
aris
radiat
oncologist
toler
heart
radiat
studi
previous
knowledg
suffici
data
collect
date
male
patient
age
year
histori
chronic
tobacco
use
alcohol
intox
present
studi
institut
patient
undergon
heart
transplant
endstag
ischem
cardiomyopathi
left
ventricl
sever
dysfunct
transplant
patient
treat
cyclosporin
azathioprin
corticoid
januari
patient
present
dysphagia
weight
loss
impair
perform
statu
ps
fibroscopi
demonstr
stenosi
larg
tumor
measur
mm
mm
mm
situat
within
cm
dental
arch
biopsi
perform
demonstr
squamou
cell
carcinoma
peritumor
lymph
node
detect
comput
tomographi
ct
scan
mediastin
lymph
node
found
distant
metastas
discuss
physician
multipl
disciplin
santylewi
surgeri
perform
final
tumor
classifi
accord
tnm
stage
system
posit
lymph
node
found
second
multidisciplinari
discuss
postop
radiotherapi
propos
conform
radiotherapi
perform
use
mv
acceler
total
dose
gray
gy
fraction
deliv
refer
point
higher
risk
transplant
heart
cardiac
structur
delin
ct
slide
heart
receiv
median
dose
gy
rang
gy
approxim
cardiac
volum
receiv
gy
strict
program
cardiac
examin
compris
electrocardiogram
cardiac
ultrasound
eject
fraction
standard
blood
test
cardiac
enzym
radiotherapi
establish
radiotherapi
well
toler
radiat
treatment
oncolog
group
rtog
grade
dysphagia
report
without
cardiac
symptom
full
cardiac
examin
perform
month
month
month
irradi
demonstr
chang
compar
pretreat
examin
left
ventricular
eject
fraction
cardiac
enzym
normal
complet
remiss
esophag
carcinoma
obtain
one
month
last
followup
month
radiotherapi
patient
die
suicid
mediastin
irradi
heart
transplant
feasibl
consid
evalu
risk
conform
radiotherapi
intensitymodul
radiotherapi
appear
appropri
treatment
ever
acut
respiratori
syndrom
sar
caus
sar
coronaviru
emerg
grave
public
health
concern
worldwid
due
potenti
nosocomi
transmiss
patient
healthcar
worker
hcw
abil
sar
lead
progress
potenti
fatal
pneumonia
without
known
effect
therapi
especi
highrisk
individu
infect
contain
strategi
utmost
import
recent
patient
suspect
sar
requir
hospit
tertiari
cancer
center
anderson
cancer
center
houston
tx
male
hodgkin
diseas
clinic
remiss
present
day
fever
nonproduct
cough
nasal
congest
headach
photophobia
symptom
commenc
return
trip
bangkok
thailand
kuala
lumpur
malaysia
singapor
june
appear
acut
ill
white
blood
cell
count
cellsl
lymphocyt
count
cell
l
chest
radiograph
show
interstiti
infiltr
right
lower
lobe
respiratori
nasopharyng
np
sampl
evalu
influenza
b
parainfluenza
respiratori
syncyti
viru
human
cytomegaloviru
sar
coronaviru
moxifloxacin
mg
trimethoprimsulfamethoxazol
mgkg
administ
empir
patient
arriv
emerg
center
ec
promptli
secur
neg
air
pressur
nap
room
secur
guard
supervis
strict
complianc
patient
contact
log
airborn
precaut
mask
contact
precaut
doubl
glove
doubl
gown
dispos
eye
shield
outer
contact
layer
dispos
insid
room
inner
layer
eye
shield
discard
immedi
outsid
room
singl
nurs
assign
patient
admit
nap
room
ventil
system
separ
unit
hous
patient
hematolog
malign
hematopoiet
stem
cell
transplant
recipi
use
ec
room
first
decontamin
thoroughli
bleach
solut
decontamin
hour
later
patient
spous
visit
daili
restrict
institut
access
patient
room
park
garag
spous
wear
mask
patientcontact
hcw
retest
mask
seal
adequaci
pulmonari
consult
obtain
portabl
mechan
ventil
cardiovascular
monitor
unit
secur
primari
oncologist
provid
nonpatientcontact
guidanc
influenza
antigen
detect
np
sampl
treatment
amantadin
mg
plu
oseltamivir
mg
initi
nonetheless
due
concern
regard
concomit
infect
infect
contain
measur
remain
uninterrupt
sar
coronaviru
cultur
serolog
assay
yield
neg
result
presenc
influenza
serotyp
confirm
patient
discharg
hour
admiss
due
uncertain
infecti
inoculum
potenti
airborn
rout
persontoperson
transmiss
devis
effect
infect
contain
strategi
daunt
task
especi
institut
promin
highrisk
popul
cautiou
infect
contain
approach
present
includ
design
hospit
unit
secur
ventil
system
restrict
institut
access
patient
famili
member
hcw
prolong
patient
exposur
identif
primari
backup
team
includ
infect
control
personnel
infecti
diseas
pulmonari
critic
care
physician
nurs
continu
infect
control
measur
result
specif
sar
coronaviru
diagnost
test
becom
avail
measur
may
serv
outlin
prevent
potenti
devast
nosocomi
spread
sar
center
provid
care
highrisk
patient
